The U.N. General Assembly voted Wednesday to label the products as medicines and require that they be marketed under the auspices of the U.K. and Canada.
It is the first time that the U., U.L. and other world powers have called on the European Union to do so.
The move comes after the European Commission raised concerns about the labeling of products produced by pharmaceutical companies.
The European Medicines Agency has said the products must be labeled as safe and effective medicines.
In a statement Wednesday, the European commission said the labels should be transparent and the names of the manufacturers and distributors of the products should be clearly visible.
The commission also asked for the names and contact details of those who produced and distributed the products to be revealed.
The council is expected to vote on a final draft resolution that would require the labels to be posted on the EU’s website.
The measure is expected for a vote on Wednesday.
In a statement, the British Foreign Office said the UK was a signatory to the World Trade Organization.
It said the move was “part of a series of initiatives to promote the protection of consumer health, including the labeling and disclosure of all the chemicals used in consumer products and health-related products.”
The U.R. has said it will not enforce the label, but its website says the labeling requirements would not apply to medicines, pharmaceuticals or medical devices.
The World Trade Organisation said the U, U.A.S., and U.C.M. are to be responsible for enforcing the label.
The U, C.M., and the UR have agreed to review their own practices to ensure compliance, it said.
More on the U-N: